The potential and pitfalls of artificial intelligence in clinical pharmacology.

Journal: CPT: pharmacometrics & systems pharmacology
Published Date:

Abstract

No abstract available for this article.

Authors

  • Martin Johnson
    Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge SG8 6HB, U.K.
  • Mishal Patel
    Clinical Pharmacology and Quantitative Pharmacology, Artificial Intelligence & Data Analytics, R&D, AstraZeneca, Cambridge, UK.
  • Alex Phipps
    Roche Pharmaceutical Research and Early Development, Roche Innovation Center Welwyn, Welwyn, UK.
  • Mihaela van der Schaar
    University of California, Los Angeles, CA, USA.
  • Dave Boulton
    Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Megan Gibbs
    Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA.